Spirometry Articles & Analysis
20 news found
Bedfont® Scientific Ltd., world leaders in breath analysis with over 47 years of knowledge in designing and manufacturing medical breath analysis devices, welcomes the recent update to the National Institute for Health and Care Excellence (NICE) guidelines on asthma management. Bedfont® manufactures the NObreath® Fractional exhaled Nitric Oxide (FeNO) device, which aids in diagnosing ...
Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by progressive scarring of the lungs, which severely impairs lung function over time. Developing effective treatments for IPF has been a challenge for the medical community, as the mechanisms driving this disease are complex and not fully understood. To accelerate drug discovery, animal models that closely mimic the ...
The rise of antibiotic-resistant bacteria has driven renewed interest in alternative treatments, including phage therapy. A recent study by Yang, F., et al (2024) explores the potential of bacteriophage therapy for treating multi-drug resistant Mycobacterium tuberculosis (Mtb) infections using humanized mouse models. This study highlights the efficacy of phage DS6A in reducing Mtb load ...
With more than 60 years’ expertise in respiratory diagnostics, Vitalograph is the only company in the world specialized in delivering clinical trial services exclusively for pulmonary function-focused studies. Speaking about the recent additions to their portfolio of services, Richard James, Executive Vice President and Chief Operating Officer of Vitalograph Clinical Trials says: ...
Vitalograph is proud to announce that it a FeNO by NIOX® UK channel partner. Spirometry and FeNO present physicians with complementary diagnostic data to inform asthma care pathways. NIOX VERO® is non-invasive, simple-to-use, and provides rapid standardised FeNO measurements. It is a point-of-care device for assessing airway inflammation in patients with respiratory problems. With over ...
Vitalograph has joined forces with MedM Inc. to further enhance patient respiratory monitoring experience with digital health capabilities. The MedM health monitoring app is paired with Vitalograph’s Asthma-1 BT and Lung Monitor BT Smart devices. The app works as a digital asthma or lung function diary, helping users to better understand and manage their condition. Patient diaries like ...
Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, in Washington. Developed in partnership with Thorasys, the Vitalograph tremoflo® C-100 oscillometer helps to detect the presence of small airway impairment, providing ...
Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, taking place in Washington. ...
NDD Medical Technologies (NDD), a leading provider of diagnostic technology enabling healthcare professionals the early detection of COPD and other chronic lung diseases, has updated the entire EasyOne® product range, including the EasyOne Air, Easy on-PC, EasyOne Pro, and EasyOne Pro LAB, to be compliant with the ATS/ERS Standardization of Spirometry 2019. Spirometry is widely used in the ...
“Quantitative imaging of the airways, for example with functional respiratory imaging (FRI), is evolving from a research tool towards clinical applications” ,Dr. Maarten van den Berge, thoracic physician at the University of Groningen, states in a recently published interview. “For the past 15 years, FEV1 measurements have been the gold standard and are included in the GOLD ...
ByFluidda
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today presented results from its Phase 1 double-blind, placebo-controlled, randomized trial of belcesiran, an investigational GalXC™ RNAi therapeutic in development for the treatment of alpha-1 antitrypsin (AAT) deficiency-associated liver disease (AATLD). ...
The role of spirometry in diagnosing and monitoring chronic obstructive airway diseases is crucial. According to WHO, the demonstration of irreversible airway obstruction is essential for diagnosing chronic obstructive pulmonary disease (COPD), which is the third leading cause of death worldwide. It is estimated that up to 67–81% of patients with COPD remain undiagnosed. Mobile phone-linked ...
ByAioCare
Ambient air pollution has many detrimental health effects, causing about seven million premature deaths annually worldwide. Children are particularly susceptible to the effects of ambient air pollution because their respiratory systems are immature. The air quality in Zabrze, a city located in the Upper Silesian Industrial Region of Poland, is among the worst in Europe. In cooperation with Polish ...
ByAioCare
Patent protected wireless lung function testing technology, Asthma, COPD, and post-COVID syndrome, Spirometry market is predicted to double in 12 months, Globalisation initiative – Europe, SE Asia and the US. Uscom notifies the market of notice to approve CE mark for the Uscom digital ultrasonic SpiroSonic AIR spirometer. The CE mark is recognition of legal compliance with health, safety ...
NDD Medical Technologies (NDD) is the leading provider of pulmonary function equipment, dedicated to the early detection and accurate diagnosis of COPD and other chronic lung diseases. In line with its continued commitment to supporting respiratory professionals—particularly in the wake of the COVID-19 pandemic—NDD is now offering free, live spirometry training sessions to provide ...
NDD Medical Technologies (NDD), a leading provider of diagnostic technology enabling healthcare professionals the early detection of COPD and other chronic lung diseases, has introduced new single patient-use, inline filters for its lung function testing devices, in response to the global COVID-19 pandemic. Ensuring an added level of safety, the new filters can be used with NDD’s ...
AioCare’s R&D team has created an AI algorithm for automatic detection of cough during spirometry testing. It was possible thanks to using neural networks and machine learning technology. The article has been published in the Informatics in Medicine Unlocked. To build the algorithm a considerable data set (about 20,000 spirometry records) was used, obtaining 93% detection accuracy. It ...
ByAioCare
The Journal of Asthma published the results of a study that assessed asthma patients and their ability to perform high-quality daily spirometry with the AioCare system. The study has shown that home spirometry is safe without supervision and feasible for asthma patients. Abstract: Background: Self-management is an appealing strategy for the prevention of asthma exacerbations. This study aimed ...
ByAioCare
Saturday 23rd of September 2017 RESTECH will participate with 2 RESMON PRO FULL devices to the “Spirometry day” organized by the Italian League against Tumor (LILT) in Bolzano. Anyone interested in having a free screening of his/her lung function can come and visit us at Piazza della Mostra from 9:00 until ...
A study just published online in the Annals of Allergy, Asthma & Immunology discusses how mold exposure may contribute to the development of childhood asthma. The study was developed to help determine if mold exposures at an early age will lead to the development of asthma. The article, entitled “High environmental relative moldiness index during infancy as a predictor of asthma at 7 ...